We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oncimmune Holdings Plc | LSE:ONC | London | Ordinary Share | GB00BYQ94H38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 3.30 | 13.47% | 27.80 | 27.80 | 29.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 28.00 | 26.00 | 26.00 | 85,037 | 14:54:01 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Medical Laboratories | 3.79M | -11.39M | -0.1639 | -1.70 | 19.31M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 10/11/2023 | 10:14 | UKREG | Oncimmune Holdings PLC Holding(s) in Company |
| 07/11/2023 | 16:11 | UKREG | Oncimmune Holdings PLC Grant of Options and PDMR Dealing |
| 19/10/2023 | 06:00 | UKREG | Oncimmune Holdings PLC Investor Presentation via Investor Meet Company |
| 12/10/2023 | 13:21 | ALNC |  IN BRIEF: Oncimmune shares jump following new strategy update |
| 12/10/2023 | 06:00 | UKREG | Oncimmune Holdings PLC Update on Strategy & Changes to the Board |
| 01/8/2023 | 06:00 | UKREG | Oncimmune Holdings PLC Board Changes |
| 14/7/2023 | 13:00 | UKREG | Oncimmune Holdings PLC Corrected unaudited interim results to 31 May 2022 |
| 12/7/2023 | 10:14 | ALNC | Oncimmune names chief executive successor, while finance chief leaves |
| 12/7/2023 | 06:00 | UKREG | Oncimmune Holdings PLC Appointment of new leadership team & board changes |
| 26/6/2023 | 10:10 | UKREG | Oncimmune Holdings PLC Change of registered office |
1 Year Oncimmune Chart |
Intraday Oncimmune Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
